Melatonin
Receptors, Melatonin
Receptor, Melatonin, MT1
Receptor, Melatonin, MT2
Pineal Gland
Circadian Rhythm
Arylalkylamine N-Acetyltransferase
Acetylserotonin O-Methyltransferase
Photoperiod
Kynuramine
Antioxidants
Sleep Disorders, Circadian Rhythm
Sleep
Drug Implants
Seasons
Melatonin biosynthesis: the structure of serotonin N-acetyltransferase at 2.5 A resolution suggests a catalytic mechanism. (1/1746)
Conversion of serotonin to N-acetylserotonin, the precursor of the circadian neurohormone melatonin, is catalyzed by serotonin N-acetyltransferase (AANAT) in a reaction requiring acetyl coenzyme A (AcCoA). AANAT is a globular protein consisting of an eight-stranded beta sheet flanked by five alpha helices; a conserved motif in the center of the beta sheet forms the cofactor binding site. Three polypeptide loops converge above the AcCoA binding site, creating a hydrophobic funnel leading toward the cofactor and serotonin binding sites in the protein interior. Two conserved histidines not found in other NATs are located at the bottom of the funnel in the active site, suggesting a catalytic mechanism for acetylation involving imidazole groups acting as general acid/base catalysts. (+info)Prolactin replacement fails to inhibit reactivation of gonadotropin secretion in rams treated with melatonin under long days. (2/1746)
This study tested the hypothesis that prolactin (PRL) inhibits gonadotropin secretion in rams maintained under long days and that treatment with melatonin (s.c. continuous-release implant; MEL-IMP) reactivates the reproductive axis by suppressing PRL secretion. Adult Soay rams were maintained under long days (16L:8D) and received 1) no further treatment (control, C); 2) MEL-IMP for 16 wk and injections of saline/vehicle for the first 8 wk (M); 3) MEL-IMP for 16 wk and exogenous PRL (s.c. 5 mg ovine PRL 3x daily) for the first 8 wk (M+P). The treatment with melatonin induced a rapid increase in the blood concentrations of FSH and testosterone, rapid growth of the testes, an increase in the frequency of LH pulses, and a decrease in the LH response to N-methyl-D,L-aspartic acid. The concomitant treatment with exogenous PRL had no effect on these reproductive responses but caused a significant delay in the timing of the sexual skin color and growth of the winter pelage. These results do not support the hypothesis and suggest that PRL at physiological long-day concentrations, while being totally ineffective as an inhibitor of gonadotropin secretion, acts in the peripheral tissues and skin to maintain summer characteristics. (+info)Melatonin inhibits release of luteinizing hormone (LH) via decrease of [Ca2+]i and cyclic AMP. (3/1746)
The role of [Ca2+]i and cAMP in transduction of the melatonin inhibitory effect on GnRH-induced LH release from neonatal rat gonadotrophs has been studied, because melatonin inhibits the increase of both intracellular messengers. Treatments increasing Ca2+ influx (S(-) Bay K8644 or KCI) or cAMP concentration (8-bromo-cAMP or 3-isobutyl-1-methylxanthine) potentiated the GnRH-induced LH release and partially diminished the inhibitory effect of melatonin. Combination of the treatments increasing cAMP and calcium concentrations blocked completely the melatonin inhibition of LH release. The combined treatment with 8-bromo-cAMP and S(-) Bay K8644 also blocked the melatonin inhibition of GnRH-induced [Ca2+]i increase in 89 % of the gonadotrophs, while any of the treatments alone blocked the melatonin effect in about 25 % of these cells. These observations suggest that a cAMP-dependent pathway is involved in regulation of Ca2+ influx by melatonin and melatonin inhibition of LH release may be mediated by the decrease of both messengers. (+info)Two arylalkylamine N-acetyltransferase genes mediate melatonin synthesis in fish. (4/1746)
Serotonin N-acetyltransferase (arylalkylamine N-acetyltransferase, AANAT, EC 2.3.1.87) is the first enzyme in the conversion of serotonin to melatonin. Large changes in AANAT activity play an important role in the daily rhythms in melatonin production. Although a single AANAT gene has been found in mammals and the chicken, we have now identified two AANAT genes in fish. These genes are designated AANAT-1 and AANAT-2; all known AANATs belong to the AANAT-1 subfamily. Pike AANAT-1 is nearly exclusively expressed in the retina and AANAT-2 in the pineal gland. The abundance of each mRNA changes on a circadian basis, with retinal AANAT-1 mRNA peaking in late afternoon and pineal AANAT-2 mRNA peaking 6 h later. The pike AANAT-1 and AANAT-2 enzymes (66% identical amino acids) exhibit marked differences in their affinity for serotonin, relative affinity for indoleethylamines versus phenylethylamines and temperature-activity relationships. Two AANAT genes also exist in another fish, the trout. The evolution of two AANATs may represent a strategy to optimally meet tissue-related requirements for synthesis of melatonin: pineal melatonin serves an endocrine role and retinal melatonin plays a paracrine role. (+info)Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms. (5/1746)
1. The circadian timing system has been implicated in age-related changes in sleep structure, timing and consolidation in humans. 2. We investigated the circadian regulation of sleep in 13 older men and women and 11 young men by forced desynchrony of polysomnographically recorded sleep episodes (total, 482; 9 h 20 min each) and the circadian rhythms of plasma melatonin and core body temperature. 3. Stage 4 sleep was reduced in older people. Overall levels of rapid eye movement (REM) sleep were not significantly affected by age. The latencies to REM sleep were shorter in older people when sleep coincided with the melatonin rhythm. REM sleep was increased in the first quarter of the sleep episode and the increase of REM sleep in the course of sleep was diminished in older people. 4. Sleep propensity co-varied with the circadian rhythms of body temperature and plasma melatonin in both age groups. Sleep latencies were longest just before the onset of melatonin secretion and short sleep latencies were observed close to the temperature nadir. In older people sleep latencies were longer close to the crest of the melatonin rhythm. 5. In older people sleep duration was reduced at all circadian phases and sleep consolidation deteriorated more rapidly during the course of sleep, especially when the second half of the sleep episode occurred after the crest of the melatonin rhythm. 6. The data demonstrate age-related decrements in sleep consolidation and increased susceptibility to circadian phase misalignment in older people. These changes, and the associated internal phase advance of the propensity to awaken from sleep, appear to be related to the interaction between a reduction in the homeostatic drive for sleep and a reduced strength of the circadian signal promoting sleep in the early morning. (+info)Potentiation of isoniazid activity against Mycobacterium tuberculosis by melatonin. (6/1746)
The limited number of effective antituberculosis drugs available necessitates optimizing current treatments. We show that melatonin, which is synthesized in the pineal gland, can cause at least a threefold increase in the efficacy of isoniazid. This suggests that tuberculosis chemotherapy can be improved by innate molecules such as melatonin. (+info)The relationship between 6-sulphatoxymelatonin and polysomnographic sleep in good sleeping controls and wake maintenance insomniacs, aged 55-80 years. (7/1746)
The pineal hormone, melatonin, is reported to possess hypnotic properties. This has led to an investigation of the relationship between the endogenous melatonin rhythm and sleep. However, this relationship has yet to be fully examined in aged insomniacs and controls. From media advertisements, 16 good sleeping controls (11F, 5M) and 16 sleep maintenance insomniacs (11F, 5M), aged over 55 years, were recruited to participate in a study involving four nights of polysomnographically (PSG) measured sleep followed by a 26 h constant routine. During the constant routine, 2 h urine samples were collected and analysed for the melatonin metabolite, 6-sulphatoxymelatonin (aMT.6S). This was used to determine total melatonin excretion. As well, the following circadian melatonin parameters were calculated from fifth order polynomial curve fitting analyses, the goodness of the polynomial curve fit, peak melatonin concentration, the phase of the melatonin rhythm, and melatonin and sleep rhythm synchrony. Apart for one control, all subjects showed significant circadian melatonin rhythms. Although insomniacs showed a greater amount of wakefulness, less sleep in total, and lower sleep efficiency, no significant group differences were observed in any of the melatonin parameters. In addition, while subjects with more reliable melatonin curve fits showed shorter sleep latencies and higher sleep efficiencies, correlational analyses revealed no other significant relationships between any melatonin and PSG sleep parameters. Overall, the present results suggest that neither melatonin amplitude nor phase are related to sleep quality in the aged. (+info)A 50-Hz electromagnetic field impairs sleep. (8/1746)
In view of reports of health problems induced by low frequency (50-60 Hz) electromagnetic fields (EMF), we carried out a study in 18 healthy subjects, comparing sleep with and without exposure to a 50 Hz/1 mu Tesla electrical field. We found that the EMF condition was associated with reduced: total sleep time (TST), sleep efficiency, stages 3 + 4 slow wave sleep (SWS), and slow wave activity (SWA). Circulating melatonin, growth hormone, prolactin, testosterone or cortisol were not affected. The results suggest that commonly occurring low frequency electromagnetic fields may interfere with sleep. (+info)Melatonin is a hormone that is produced by the pineal gland in the brain. It helps regulate sleep-wake cycles and is often referred to as the "hormone of darkness" because its production is stimulated by darkness and inhibited by light. Melatonin plays a key role in synchronizing the circadian rhythm, the body's internal clock that regulates various biological processes over a 24-hour period.
Melatonin is primarily released at night, and its levels in the blood can rise and fall in response to changes in light and darkness in an individual's environment. Supplementing with melatonin has been found to be helpful in treating sleep disorders such as insomnia, jet lag, and delayed sleep phase syndrome. It may also have other benefits, including antioxidant properties and potential uses in the treatment of certain neurological conditions.
It is important to note that while melatonin supplements are available over-the-counter in many countries, they should still be used under the guidance of a healthcare professional, as their use can have potential side effects and interactions with other medications.
Melatonin receptors are a type of G protein-coupled receptor (GPCR) that bind to the hormone melatonin in animals. These receptors play a crucial role in regulating various physiological functions, including sleep-wake cycles, circadian rhythms, and seasonal reproduction.
There are two main types of melatonin receptors: MT1 (also known as Mel1a) and MT2 (Mel1b). Both receptor subtypes are widely expressed in the central nervous system, retina, and peripheral tissues. The activation of these receptors by melatonin leads to a range of downstream signaling events that ultimately result in changes in gene expression, cellular responses, and physiological processes.
MT1 receptors are involved in regulating sleep onset and promoting non-rapid eye movement (NREM) sleep. They have also been implicated in the regulation of mood, anxiety, and cognitive function. MT2 receptors play a role in regulating circadian rhythms and the timing of sleep-wake cycles. They are also involved in the regulation of pupillary light reflex, body temperature, and blood pressure.
Dysregulation of melatonin receptor signaling has been implicated in various sleep disorders, mood disorders, and neurodegenerative diseases. Therefore, understanding the function and regulation of melatonin receptors is an important area of research for developing novel therapeutic strategies for these conditions.
A melatonin receptor is a type of G protein-coupled receptor (GPCR) that binds to the hormone melatonin, which plays a crucial role in regulating sleep-wake cycles and other physiological functions. There are two main types of melatonin receptors: MT1 (also known as Mel1a or MTNR1A) and MT2 (also known as Mel1b or MTNR1B).
MT1 receptor, specifically, is a gene that encodes for the MT1 melatonin receptor protein. This receptor is primarily expressed in the suprachiasmatic nucleus (SCN) of the hypothalamus, which is the body's central circadian pacemaker, as well as in various other tissues such as the retina, pineal gland, and peripheral blood vessels. The activation of MT1 receptors by melatonin can lead to a variety of downstream effects, including the regulation of sleep onset and duration, circadian rhythm entrainment, and the modulation of mood and cognitive function. Additionally, MT1 receptors have been implicated in the regulation of several other physiological processes such as blood pressure, body temperature, and immune function.
A melatonin receptor is a type of G protein-coupled receptor (GPCR) that binds to the hormone melatonin, which is primarily involved in regulating sleep-wake cycles. There are two main subtypes of melatonin receptors, MT1 and MT2, which are encoded by the genes MTNR1A and MTNR1B, respectively.
MT2 receptor, also known as Mel1b or MTNR1B, is a subtype of melatonin receptor that is widely expressed in various tissues, including the retina, brain, heart, and gastrointestinal tract. MT2 receptors are involved in several physiological functions, such as circadian rhythm regulation, sleep onset and duration, and neuroprotection.
MT2 receptor activation has been shown to promote sleep onset and consolidation, reduce anxiety and depressive-like behaviors, and improve cognitive function. Additionally, MT2 receptors have been implicated in the regulation of glucose metabolism, insulin secretion, and energy homeostasis, suggesting a potential role in the treatment of metabolic disorders such as diabetes.
Overall, melatonin receptors, particularly the MT2 subtype, are important targets for developing therapies for sleep disorders, neuropsychiatric conditions, and metabolic diseases.
The pineal gland, also known as the epiphysis cerebri, is a small endocrine gland located in the brain. It is shaped like a pinecone, hence its name, and is situated near the center of the brain, between the two hemispheres, attached to the third ventricle. The primary function of the pineal gland is to produce melatonin, a hormone that helps regulate sleep-wake cycles and circadian rhythms in response to light and darkness. Additionally, it plays a role in the onset of puberty and has been suggested to have other functions related to cognition, mood, and reproduction, although these are not as well understood.
A circadian rhythm is a roughly 24-hour biological cycle that regulates various physiological and behavioral processes in living organisms. It is driven by the body's internal clock, which is primarily located in the suprachiasmatic nucleus (SCN) of the hypothalamus in the brain.
The circadian rhythm controls many aspects of human physiology, including sleep-wake cycles, hormone secretion, body temperature, and metabolism. It helps to synchronize these processes with the external environment, particularly the day-night cycle caused by the rotation of the Earth.
Disruptions to the circadian rhythm can have negative effects on health, leading to conditions such as insomnia, sleep disorders, depression, bipolar disorder, and even increased risk of chronic diseases like cancer, diabetes, and cardiovascular disease. Factors that can disrupt the circadian rhythm include shift work, jet lag, irregular sleep schedules, and exposure to artificial light at night.
Arylalkylamine N-acetyltransferase (AANAT) is an enzyme that plays a crucial role in the regulation of melatonin synthesis in the body. It catalyzes the acetylation of serotonin to produce N-acetylserotonin, which is then converted to melatonin by the enzyme acetylserotonin O-methyltransferase (ASMT).
Melatonin is a hormone that helps regulate sleep-wake cycles and other physiological processes in the body. The activity of AANAT is influenced by light exposure, with higher levels of activity occurring in darkness and lower levels during light exposure. This allows melatonin production to be synchronized with the day-night cycle, contributing to the regulation of circadian rhythms.
Genetic variations in the AANAT gene have been associated with differences in sleep patterns, mood regulation, and other physiological processes. Dysregulation of AANAT activity has been implicated in various conditions, including insomnia, depression, and seasonal affective disorder.
Acetylserotonin O-methyltransferase (ASMT) is an enzyme that catalyzes the final step in melatonin synthesis. It transfers a methyl group from S-adenosylmethionine to acetylserotonin, forming melatonin and S-adenosylhomocysteine. ASMT plays a crucial role in regulating the sleep-wake cycle and other physiological processes influenced by melatonin.
Tryptamines are a class of organic compounds that contain a tryptamine skeleton, which is a combination of an indole ring and a ethylamine side chain. They are commonly found in nature and can be synthesized in the lab. Some tryptamines have psychedelic properties and are used as recreational drugs, such as dimethyltryptamine (DMT) and psilocybin. Others have important roles in the human body, such as serotonin, which is a neurotransmitter that regulates mood, appetite, and sleep. Tryptamines can also be found in some plants and animals, including certain species of mushrooms, toads, and catnip.
Photoperiod is a term used in chronobiology, which is the study of biological rhythms and their synchronization with environmental cycles. In medicine, photoperiod specifically refers to the duration of light and darkness in a 24-hour period, which can significantly impact various physiological processes in living organisms, including humans.
In human medicine, photoperiod is often considered in relation to circadian rhythms, which are internal biological clocks that regulate several functions such as sleep-wake cycles, hormone secretion, and metabolism. The length of the photoperiod can influence these rhythms and contribute to the development or management of certain medical conditions, like mood disorders, sleep disturbances, and metabolic disorders.
For instance, exposure to natural daylight or artificial light sources with specific intensities and wavelengths during particular times of the day can help regulate circadian rhythms and improve overall health. Conversely, disruptions in the photoperiod due to factors like shift work, jet lag, or artificial lighting can lead to desynchronization of circadian rhythms and related health issues.
In the context of medical terminology, "light" doesn't have a specific or standardized definition on its own. However, it can be used in various medical terms and phrases. For example, it could refer to:
1. Visible light: The range of electromagnetic radiation that can be detected by the human eye, typically between wavelengths of 400-700 nanometers. This is relevant in fields such as ophthalmology and optometry.
2. Therapeutic use of light: In some therapies, light is used to treat certain conditions. An example is phototherapy, which uses various wavelengths of ultraviolet (UV) or visible light for conditions like newborn jaundice, skin disorders, or seasonal affective disorder.
3. Light anesthesia: A state of reduced consciousness in which the patient remains responsive to verbal commands and physical stimulation. This is different from general anesthesia where the patient is completely unconscious.
4. Pain relief using light: Certain devices like transcutaneous electrical nerve stimulation (TENS) units have a 'light' setting, indicating lower intensity or frequency of electrical impulses used for pain management.
Without more context, it's hard to provide a precise medical definition of 'light'.
Kynurenine aminotransferase (also known as Kynuramine transaminase) is an enzyme that plays a role in the metabolism of the amino acid tryptophan. This enzyme catalyzes the conversion of kynurenine to kynurenic acid, which is a neuroprotective compound.
Kynurenine and kynurenic acid are both important components of the kynurenine pathway, which is a major metabolic route for tryptophan in mammals. The kynurenine pathway plays a role in various physiological processes, including the immune response and the regulation of neurotransmission.
Abnormalities in the kynurenine pathway have been implicated in several neurological and psychiatric disorders, such as Alzheimer's disease, Parkinson's disease, schizophrenia, and depression. Therefore, understanding the enzymes involved in this pathway, including kynuramine transaminase, is important for gaining insights into the underlying mechanisms of these diseases and for developing potential therapeutic strategies.
Antioxidants are substances that can prevent or slow damage to cells caused by free radicals, which are unstable molecules that the body produces as a reaction to environmental and other pressures. Antioxidants are able to neutralize free radicals by donating an electron to them, thus stabilizing them and preventing them from causing further damage to the cells.
Antioxidants can be found in a variety of foods, including fruits, vegetables, nuts, and grains. Some common antioxidants include vitamins C and E, beta-carotene, and selenium. Antioxidants are also available as dietary supplements.
In addition to their role in protecting cells from damage, antioxidants have been studied for their potential to prevent or treat a number of health conditions, including cancer, heart disease, and age-related macular degeneration. However, more research is needed to fully understand the potential benefits and risks of using antioxidant supplements.
A Circadian Rhythm Sleep Disorder (CRSD) is a condition in which a person's sleep-wake cycle is out of sync with the typical 24-hour day. This means that their internal "body clock" that regulates sleep and wakefulness does not align with the external environment, leading to difficulties sleeping, staying awake, or functioning at appropriate times.
CRSDs can be caused by a variety of factors, including genetic predisposition, environmental influences, and medical conditions. Some common types of CRSDs include Delayed Sleep Phase Syndrome (DSPS), Advanced Sleep Phase Syndrome (ASPS), Non-24-Hour Sleep-Wake Rhythm Disorder, and Shift Work Disorder.
Symptoms of CRSDs may include difficulty falling asleep or staying asleep at the desired time, excessive sleepiness during the day, difficulty concentrating or functioning at work or school, and mood disturbances. Treatment for CRSDs may involve lifestyle changes, such as adjusting sleep schedules or exposure to light at certain times of day, as well as medications or other therapies.
Sleep is a complex physiological process characterized by altered consciousness, relatively inhibited sensory activity, reduced voluntary muscle activity, and decreased interaction with the environment. It's typically associated with specific stages that can be identified through electroencephalography (EEG) patterns. These stages include rapid eye movement (REM) sleep, associated with dreaming, and non-rapid eye movement (NREM) sleep, which is further divided into three stages.
Sleep serves a variety of functions, including restoration and strengthening of the immune system, support for growth and development in children and adolescents, consolidation of memory, learning, and emotional regulation. The lack of sufficient sleep or poor quality sleep can lead to significant health problems, such as obesity, diabetes, cardiovascular disease, and even cognitive decline.
The American Academy of Sleep Medicine (AASM) defines sleep as "a period of daily recurring natural rest during which consciousness is suspended and metabolic processes are reduced." However, it's important to note that the exact mechanisms and purposes of sleep are still being researched and debated among scientists.
5-Methoxytryptamine is a psychedelic tryptamine that is found in some plants and animals, as well as being produced synthetically. It is structurally similar to the neurotransmitter serotonin and is known for its ability to alter perception, thought, and mood. 5-Methoxytryptamine is also referred to as "mexamine" or "O-methylated tryptamine." It is a Schedule I controlled substance in the United States, making it illegal to possess or distribute without a license from the Drug Enforcement Administration (DEA).
In the medical field, 5-Methoxytryptamine does not have a specific use as a medication. However, it has been used in some research settings to study its effects on the brain and behavior. It is important to note that the use of 5-Methoxytryptamine or any other psychedelic substance should only be done under the supervision of trained medical professionals in a controlled setting due to the potential risks associated with their use.
A drug implant is a medical device that is specially designed to provide controlled release of a medication into the body over an extended period of time. Drug implants can be placed under the skin or in various body cavities, depending on the specific medical condition being treated. They are often used when other methods of administering medication, such as oral pills or injections, are not effective or practical.
Drug implants come in various forms, including rods, pellets, and small capsules. The medication is contained within the device and is released slowly over time, either through diffusion or erosion of the implant material. This allows for a steady concentration of the drug to be maintained in the body, which can help to improve treatment outcomes and reduce side effects.
Some common examples of drug implants include:
1. Hormonal implants: These are small rods that are inserted under the skin of the upper arm and release hormones such as progestin or estrogen over a period of several years. They are often used for birth control or to treat conditions such as endometriosis or uterine fibroids.
2. Intraocular implants: These are small devices that are placed in the eye during surgery to release medication directly into the eye. They are often used to treat conditions such as age-related macular degeneration or diabetic retinopathy.
3. Bone cement implants: These are specially formulated cements that contain antibiotics and are used to fill bone defects or joint spaces during surgery. The antibiotics are released slowly over time, helping to prevent infection.
4. Implantable pumps: These are small devices that are placed under the skin and deliver medication directly into a specific body cavity, such as the spinal cord or the peritoneal cavity. They are often used to treat chronic pain or cancer.
Overall, drug implants offer several advantages over other methods of administering medication, including improved compliance, reduced side effects, and more consistent drug levels in the body. However, they may also have some disadvantages, such as the need for surgical placement and the potential for infection or other complications. As with any medical treatment, it is important to discuss the risks and benefits of drug implants with a healthcare provider.
I'm sorry for any confusion, but "seasons" is not a term that has a medical definition. Seasons refer to the four divisions of the year (spring, summer, autumn or fall, and winter) based on the position of the earth in its orbit around the sun. If you have any questions related to health or medicine, I'd be happy to try to help answer those!
Chronobiology disorders are a group of conditions that involve disruptions in the body's internal biological clock, which regulates various physiological processes such as sleep-wake cycles, hormone release, and metabolism. These disorders can result in a variety of symptoms, including difficulty sleeping, changes in mood and energy levels, and problems with cognitive function.
Some common examples of chronobiology disorders include:
1. Delayed Sleep Phase Syndrome (DSPS): This condition is characterized by a persistent delay in the timing of sleep, so that an individual's preferred bedtime is significantly later than what is considered normal. As a result, they may have difficulty falling asleep and waking up at socially acceptable times.
2. Advanced Sleep Phase Syndrome (ASPS): In this condition, individuals experience an earlier-than-normal timing of sleep, so that they become sleepy and wake up several hours earlier than most people.
3. Non-24-Hour Sleep-Wake Rhythm Disorder: This disorder is characterized by a persistent mismatch between the individual's internal biological clock and the 24-hour day, resulting in irregular sleep-wake patterns that can vary from day to day.
4. Irregular Sleep-Wake Rhythm Disorder: In this condition, individuals experience a lack of consistent sleep-wake patterns, with multiple periods of sleep and wakefulness throughout the 24-hour day.
5. Shift Work Sleep Disorder: This disorder is caused by the disruption of normal sleep-wake patterns due to working irregular hours, such as night shifts or rotating schedules.
6. Jet Lag Disorder: This condition occurs when an individual travels across time zones and experiences a temporary mismatch between their internal biological clock and the new local time.
Treatment for chronobiology disorders may include lifestyle changes, such as adjusting sleep schedules and exposure to light, as well as medications that can help regulate sleep-wake cycles. In some cases, cognitive-behavioral therapy (CBT) may also be helpful in managing these conditions.